 NEW YORK, Dec. 11, 2020 GLOBE NEWSWIRE -- PAVmed Inc. Nasdaq: PAVM, PAVMZ the Company or PAVmed, a highly differentiated, multi-product, commercial-stage medical device company, today announced it has entered into agreements for the sale of 5.6 million shares of common stock in a registered direct offering at a price of 1.60 per share for gross proceeds of approximately 8.9 million. 